Astellas Unit Expands Seattle Genetics Partnership For Developing Antibodies
This article was originally published in PharmAsia News
Executive Summary
Astellas Pharma affiliate Agensys has increased its collaboration with fellow U.S. device maker Seattle Genetics for developing antibodies